
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11217794
[patent_doc_number] => 09446113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens'
[patent_app_type] => utility
[patent_app_number] => 14/687463
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14010
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14687463
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/687463 | Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens | Apr 14, 2015 | Issued |
Array
(
[id] => 10405159
[patent_doc_number] => 20150290168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'CLASS IIA HDAC INHIBITORS FOR THE TREATMENT OF INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/682263
[patent_app_country] => US
[patent_app_date] => 2015-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12675
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14682263
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/682263 | Class IIa HDAC inhibitors for the treatment of infection | Apr 8, 2015 | Issued |
Array
(
[id] => 11304819
[patent_doc_number] => 09512204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Humanized pertussis antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/675514
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 24744
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14675514
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/675514 | Humanized pertussis antibodies and uses thereof | Mar 30, 2015 | Issued |
Array
(
[id] => 10400789
[patent_doc_number] => 20150285798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING, TREATING AND MONITORING ACTIVE BORRELIA INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/644418
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13245
[patent_no_of_claims] => 107
[patent_no_of_ind_claims] => 80
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14644418
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/644418 | COMPOSITIONS AND METHODS FOR DETECTING, TREATING AND MONITORING ACTIVE BORRELIA INFECTION | Mar 10, 2015 | Abandoned |
Array
(
[id] => 11407801
[patent_doc_number] => 09555088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-31
[patent_title] => 'DNA vector and transformed tumor cell vaccines'
[patent_app_type] => utility
[patent_app_number] => 15/110248
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 9771
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110248 | DNA vector and transformed tumor cell vaccines | Mar 3, 2015 | Issued |
Array
(
[id] => 10354784
[patent_doc_number] => 20150239789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'COMPETITIVE AND EFFECTIVE BACTERIAL STRAINS'
[patent_app_type] => utility
[patent_app_number] => 14/636829
[patent_app_country] => US
[patent_app_date] => 2015-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13495
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14636829
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/636829 | Competitive and effective bacterial strains | Mar 2, 2015 | Issued |
Array
(
[id] => 11046253
[patent_doc_number] => 20160243210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'METHODS AND COMPOSITIONS BASED ON SHIGA TOXIN TYPE 2 PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/628667
[patent_app_country] => US
[patent_app_date] => 2015-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17943
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14628667
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/628667 | Methods and compositions based on Shiga toxin type 2 protein | Feb 22, 2015 | Issued |
Array
(
[id] => 10356421
[patent_doc_number] => 20150241426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'METHOD FOR DETECTING INFECTION BY DETECTING INFECTIOUS AGENT ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/618103
[patent_app_country] => US
[patent_app_date] => 2015-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2813
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14618103
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/618103 | METHOD FOR DETECTING INFECTION BY DETECTING INFECTIOUS AGENT ANTIGENS | Feb 9, 2015 | |
Array
(
[id] => 10684399
[patent_doc_number] => 20160030543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/604620
[patent_app_country] => US
[patent_app_date] => 2015-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 40599
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604620
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/604620 | Neisseria meningitidis compositions and methods thereof | Jan 22, 2015 | Issued |
Array
(
[id] => 11794454
[patent_doc_number] => 09404208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Mitigation of odor in cleaning machines and cleaning processes'
[patent_app_type] => utility
[patent_app_number] => 14/596717
[patent_app_country] => US
[patent_app_date] => 2015-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23744
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14596717
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/596717 | Mitigation of odor in cleaning machines and cleaning processes | Jan 13, 2015 | Issued |
Array
(
[id] => 10987274
[patent_doc_number] => 20160184219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'Use of Genetically Modified Skin Flora for Body Odor Relief in Intertriginous Areas'
[patent_app_type] => utility
[patent_app_number] => 14/583887
[patent_app_country] => US
[patent_app_date] => 2014-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1175
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14583887
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/583887 | Use of Genetically Modified Skin Flora for Body Odor Relief in Intertriginous Areas | Dec 28, 2014 | Abandoned |
Array
(
[id] => 10289232
[patent_doc_number] => 20150174230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'CHIMERIC PROTEIN VACCINE AGAINST PNEUMONIA CAUSED BY STREPTOCOCCUS PNEUMONIAE'
[patent_app_type] => utility
[patent_app_number] => 14/579279
[patent_app_country] => US
[patent_app_date] => 2014-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5185
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579279
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/579279 | Chimeric protein vaccine against pneumonia caused by Streptococcus pneumoniae | Dec 21, 2014 | Issued |
Array
(
[id] => 11419853
[patent_doc_number] => 20170027997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'LACTOBACILLUS SALIVARIUS FOR THE TREATMENT OF MASTITIS'
[patent_app_type] => utility
[patent_app_number] => 15/105774
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12023
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105774
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105774 | None | Dec 18, 2014 | Issued |
Array
(
[id] => 9930934
[patent_doc_number] => 20150079127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'CANINE BABESIOSIS VACCINE ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 14/557833
[patent_app_country] => US
[patent_app_date] => 2014-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15010
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14557833
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/557833 | Canine babesiosis vaccine antigen | Dec 1, 2014 | Issued |
Array
(
[id] => 9909009
[patent_doc_number] => 20150064211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'SYNTHETIC ACTIVE PEPTIDE FRAGMENTS'
[patent_app_type] => utility
[patent_app_number] => 14/539248
[patent_app_country] => US
[patent_app_date] => 2014-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12104
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14539248
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/539248 | Synthetic active peptide fragments | Nov 11, 2014 | Issued |
Array
(
[id] => 10782182
[patent_doc_number] => 20160128338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'COMPOSITION AND METHODS FOR IMPROVED TURF HEALTH'
[patent_app_type] => utility
[patent_app_number] => 14/534528
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3679
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14534528
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/534528 | COMPOSITION AND METHODS FOR IMPROVED TURF HEALTH | Nov 5, 2014 | Abandoned |
Array
(
[id] => 12226631
[patent_doc_number] => 09913857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-13
[patent_title] => 'Composition and methods of screening'
[patent_app_type] => utility
[patent_app_number] => 15/034420
[patent_app_country] => US
[patent_app_date] => 2014-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 33
[patent_no_of_words] => 5990
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034420
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/034420 | Composition and methods of screening | Nov 4, 2014 | Issued |
Array
(
[id] => 9895115
[patent_doc_number] => 20150050314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'CONJUGATES OF PLASMODIUM FALCIPARUM SURFACE PROTEINS AS MALARIA VACCINES'
[patent_app_type] => utility
[patent_app_number] => 14/527676
[patent_app_country] => US
[patent_app_date] => 2014-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9751
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14527676
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/527676 | CONJUGATES OF PLASMODIUM FALCIPARUM SURFACE PROTEINS AS MALARIA VACCINES | Oct 28, 2014 | Abandoned |
Array
(
[id] => 10234282
[patent_doc_number] => 20150119276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'IMMUNOREACTIVE EHRLICHIA P120/P140 EPITOPES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/516828
[patent_app_country] => US
[patent_app_date] => 2014-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27666
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14516828
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/516828 | Immunoreactive Ehrlichia p120/p140 epitopes and uses thereof | Oct 16, 2014 | Issued |
Array
(
[id] => 10247340
[patent_doc_number] => 20150132336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/514625
[patent_app_country] => US
[patent_app_date] => 2014-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 41147
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14514625
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/514625 | Immunogenic compositions of Staphylococcus aureus antigens | Oct 14, 2014 | Issued |